TCM Biotech International Corp. (4169.TWO)
TWD 58.3
(0.52%)
TWD 58.3
(0.52%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -37.53 Million | 52.24 Million | 15.32 Million | 74.9 Million | -20.88 Million |
| Net Income | 22.03 Million | 23.12 Million | 2.25 Million | 36.13 Million | 6.51 Million |
| Depreciation & Amortization | 21.89 Million | 20 Million | 18.05 Million | 15.06 Million | 15.87 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 1.95 Million | - | 1.73 Million | - | - |
| Change in working capital | -80.17 Million | 7.29 Million | -2.28 Million | 29.57 Million | -33.28 Million |
| Other non-cash items | 1.22 Million | 3.57 Million | 1.93 Million | 1.87 Million | -9.99 Million |
| Investing Cash Flow | -4.51 Million | -8.09 Million | -19.6 Million | -25.54 Million | 21.93 Million |
| Investments in PPE | -4.91 Million | -5.28 Million | -7.71 Million | -21.68 Million | -2.27 Million |
| Acquisitions | 1.32 Million | - | - | - | - |
| Investment purchases | - | -90 Thousand | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -935 Thousand | -2.71 Million | -13.85 Million | -5.85 Million | 24.2 Million |
| Financing Cash Flow | 456.3 Million | -12.43 Million | 28.23 Million | -44.37 Million | -27.14 Million |
| Debt repayment | -39.13 Million | -9.69 Million | -34.22 Million | -24.24 Million | -10.82 Million |
| Dividends payments | -1.61 Million | - | -16.91 Million | -18.79 Million | -17.85 Million |
| Common Stock Repurchased | - | - | - | - | -13.09 Million |
| Common Stock Issuance | 500 Million | - | 13.09 Million | - | - |
| Other Financing Activities | 500 Million | 112 Thousand | 57.09 Million | 158 Thousand | -13.09 Million |
| Accounts receivables | -27.69 Million | -35.12 Million | -22.2 Million | -7.61 Million | 39.01 Million |
| Accounts payables | -18.69 Million | - | - | - | - |
| Inventory | -13.33 Million | 4.74 Million | -3.27 Million | 9 Million | -45.73 Million |
| Other working capital | -23.17 Million | 33.76 Million | 3.73 Million | 13.99 Million | -26.56 Million |
| Cash at beginning of period | 89.84 Million | 58.25 Million | 34.26 Million | 29.25 Million | 55.32 Million |
| Cash at end of period | 504.13 Million | 89.84 Million | 58.25 Million | 34.26 Million | 29.25 Million |
| Capital Expenditure | -4.91 Million | -5.28 Million | -7.71 Million | -21.68 Million | -2.27 Million |
| Effect of forex changes on cash | 41 Thousand | -121 Thousand | 32 Thousand | 27 Thousand | 36 Thousand |
| Net cash flow / Change in cash | 414.28 Million | 31.59 Million | 23.98 Million | 5 Million | -26.06 Million |
| Free Cash Flow | -42.44 Million | 46.95 Million | 7.61 Million | 53.22 Million | -23.16 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 4.92 Million | 4.92 Million | 22.03 Million | 5.07 Million | 5.07 Million | 4.21 Million |
| Depreciation & Amortization | 5.89 Million | 5.89 Million | 21.89 Million | 5.54 Million | 5.09 Million | 5 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 1.95 Million | 975 Thousand | 975 Thousand | - |
| Change in working capital | 50.42 Million | 50.42 Million | -80.17 Million | -19.36 Million | -19.36 Million | -12.73 Million |
| Other non-cash items | -22.01 Million | -22.01 Million | 1.22 Million | -6.31 Million | -5.86 Million | -1.16 Million |
| Investing Cash Flow | -102.75 Million | -102.75 Million | -4.51 Million | 80 Thousand | 80 Thousand | -2.33 Million |
| Investments in PPE | -809.5 Thousand | -809.5 Thousand | -4.91 Million | -606.5 Thousand | -606.5 Thousand | -1.38 Million |
| Acquisitions | 286 Thousand | - | - | 1.07 Million | - | - |
| Investment purchases | -200 Million | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | -90 Thousand | - | - |
| Other Investing Activities | -101.94 Million | -101.94 Million | -935 Thousand | 686.5 Thousand | 686.5 Thousand | -958 Thousand |
| Financing Cash Flow | -1.89 Million | -1.89 Million | 456.3 Million | 231.27 Million | 231.27 Million | -3.12 Million |
| Debt repayment | -5.9 Million | - | -39.13 Million | -38.93 Million | - | - |
| Dividends payments | - | - | -1.61 Million | -809 Thousand | -809 Thousand | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 500 Million | 500 Million | - | - |
| Other Financing Activities | -1.89 Million | -1.89 Million | 500 Million | 232.08 Million | 232.08 Million | -3.12 Million |
| Accounts receivables | 62.54 Million | 62.54 Million | -27.69 Million | -5.63 Million | -5.63 Million | -8.21 Million |
| Accounts payables | -42.26 Million | - | - | -15.73 Million | - | - |
| Inventory | 17.07 Million | 17.07 Million | -13.33 Million | -8.51 Million | -8.51 Million | 1.85 Million |
| Other working capital | -29.19 Million | -29.19 Million | -23.17 Million | -5.21 Million | -5.21 Million | -6.37 Million |
| Cash at beginning of period | 504.13 Million | - | 89.84 Million | 69.67 Million | - | - |
| Cash at end of period | 373.32 Million | -65.4 Million | 504.13 Million | 217.22 Million | 217.22 Million | -10.08 Million |
| Capital Expenditure | -809.5 Thousand | -809.5 Thousand | -4.91 Million | -606.5 Thousand | -606.5 Thousand | -1.38 Million |
| Effect of forex changes on cash | 7500.00 | 7500.00 | 41 Thousand | -42 Thousand | -42 Thousand | 62.5 Thousand |
| Net cash flow / Change in cash | -130.81 Million | -65.4 Million | 414.28 Million | 147.55 Million | 217.22 Million | -10.08 Million |
| Free Cash Flow | 38.42 Million | 38.42 Million | -42.44 Million | -14.68 Million | -14.68 Million | -6.06 Million |
ASTC
1295
600309
1459
1385
CYAN